Cosmos Health Inc. (NASDAQ:COSM) Short Interest Down 19.5% in March

Cosmos Health Inc. (NASDAQ:COSM) saw a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 646,900 shares, a drop of 19.5% from the February 28th total of 804,000 shares. Currently, 4.0% of the shares of the company are sold short. Based on an average daily volume of 414,400 shares, the short-interest ratio is presently 1.6 days.

Insider Transactions at Cosmos Health

In other news, CEO Grigorios Siokas acquired 62,500 shares of the stock in a transaction that occurred on Wednesday, January 15th. The shares were acquired at an average cost of $0.80 per share, for a total transaction of $50,000.00. Following the purchase, the chief executive officer now owns 4,087,727 shares of the company’s stock, valued at approximately $3,270,181.60. The trade was a 1.55 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders purchased a total of 832,506 shares of company stock worth $502,164 in the last quarter. Insiders own 15.61% of the company’s stock.

Institutional Investors Weigh In On Cosmos Health

A hedge fund recently raised its stake in Cosmos Health stock. Geode Capital Management LLC lifted its position in Cosmos Health Inc. (NASDAQ:COSM) by 29.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 193,432 shares of the company’s stock after acquiring an additional 43,704 shares during the period. Geode Capital Management LLC owned 0.83% of Cosmos Health worth $129,000 as of its most recent SEC filing. 12.61% of the stock is currently owned by institutional investors and hedge funds.

Cosmos Health Trading Down 2.1 %

Shares of Cosmos Health stock opened at $0.43 on Wednesday. The company’s 50-day moving average price is $0.59 and its 200-day moving average price is $0.70. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08. Cosmos Health has a 12-month low of $0.35 and a 12-month high of $1.58. The company has a market cap of $9.93 million, a price-to-earnings ratio of -0.17 and a beta of 5.60.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.